This topic contains a solution. Click here to go to the answer

Author Question: Memory for names and concepts in a cognitive psychology course stabilizes at above-chance levels ... (Read 51 times)

acc299

  • Hero Member
  • *****
  • Posts: 569
Memory for names and concepts in a cognitive psychology course stabilizes at above-chance levels after how many years of retention?
 
  a. 1 year c. 5 years
  b. 3 years d. 10 years

Question 2

Attention is not a part of traditional models of short-term memory.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CAPTAINAMERICA

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

B

Answer to Question 2

T




acc299

  • Member
  • Posts: 569
Reply 2 on: Jun 20, 2018
:D TYSM


jomama

  • Member
  • Posts: 346
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library